1. Case Studies in the Management
of HIV-Positive Patients
Stephen Perez, RN, NP, AAHIV-S
2. Overview and Objectives
• Review case studies involving the
management of HIV-infected patient
• Apply knowledge to determine
appropriate ARV initiation and
management for case patients
• Engage in group discussion around the
complexities of initiating ARV’s
2
3. Case One: Juan
• 25 y.o. Salvadorian, bisexual male.
• Tested HIV-positive 4 weeks ago after
visiting a county clinic and being
treated for GC/CT
• He is presenting for his first visit with you
today
• Prior to his visit to the county clinic, he
has not had care since 1 year ago, he
has not had primary care since
childhood
4. Case One: Juan
• Juan brings a copy of
his records from the
county clinic
– RX with Rocephin and
Azithromycin
– Twinrix #1
– Positive HIV WB
– Positive GC NAAT
(urine), RPR non-
reactive, neg CT NAAT
(urine).
– Information flyer for
your clinic
4
5. Case One: Juan
• On initial history:
– UTI symptoms 6 weeks ago, now
resolved
– No other recent illnesses
– No history of chronic illness
– Family history relatively unknown
• Married with one child in El Salvador
– No Surgical Hx
– ED visit 1 year ago for
CAP, resolved with abx, prior ED
visit 3 years ago, for laceration
at work
– NKDA, no current meds 5
7. Case One: Juan
• What other information do we want to know about Juan?
• Previous testing
– No previous HIV tests or STD history, no hx of ARV’s
• ETOH, Illicit Drugs
– Drinks alcohol 3-4 times a week, intoxicated 2 times a
week (approx. 8 beers)
• Sexual Activity
– Sexually active with 2 male partners last sexual activity last
week. Oral sex (no condoms), receptive anal sex (with
condoms)
• Work History
– Works as a cook at a local 24 hour restaurant. He works
alternate day and night shifts
• Immunizations
– Unknown, received a “shot” at the ED 3 years ago after
sutures
• Mental Health History
7
– None reported
8. Case One: Juan
• Physical Exam
– WNWD, NAD, BMI 26, VS wnl
– Mild palpable LN in anterior cervical chain
– 4cm well healed scar on left palm
– Otherwise unremarkable
8
9. Case One: Juan
• What Lab Tests Do We Want to Order?
– CD4 count
– Viral Load
– CMP/CBC
– Hepatitis Serologies (HAV, HBV, HCV)
– Urinalysis
– Genotype
– Fasting Plasma Glucose, Fasting Lipids
– Repeat Urine GC/CT, Throat GC/CT
– PPD
– Anti-Toxoplasma IgG
9
10. Case One: Juan
• Results
– CBC/CMP within normal
– CD4 644, VL is 56,346
– HBsAg neg, anti HBc Ab positive, anti HBs Ab
positive, Total anti-HAV Ab postive, anti HCV
Ab neg.
– UA wnl
– Genotype is pan-sensitive
– Lipids: TC-1, LDL-130, HDL-50, TG-200.
– FPG: 98
– Repeat GC/CT negative
– PPD 0mm, anti-toxo is <6.5
10
11. Case One: Juan
Should Juan Start Antiretroviral Therapy
(Audience Response)?
1. Yes
2. No
3. Maybe So
11
12. Case One: Juan
• What ARV’s Would You
Recommend for Juan?
– ARV Naïve
– Genotype is pan-sensitive
– Works odd hours
12
13. Case One: Juan
What ARV’s Would You
Recommend for Juan?
(Audience Response)
1. Atripla (EFV/TDF/FTC)
2. Prezista, Norvir and
Truvada (DAR/r +
TDF/FTC)
3. Reyataz, Norvir and
Truvada (ATV/r
+TDF/FTC)
4. Isentress and Truvada
(RAL + TDF/FTC)
5. Complera
13
(RPV/FTC/TDF)
14. Case One: Juan
• What are benefits
and risks of your
selected ARV
regimen?
• If starting Juan at his
next visit, when do
you want him to
return for follow-up?
• How would you
monitor his response
to therapy?
14
16. Case Two: Janice
• 34 year-old A.A. female with HIV
infection
• She was diagnosed 4 years ago when
she presented to an OB clinic at 26
weeks, but has not been engaged in
care since her delivery.
• She recently moved to the area, and is
concerned because she has been
feeling tired. Also has some intermittent
throat pain
16
17. Case Two: Janice
• She does not have
her previous records
with her but tells you
the following
– She took HIV meds
during pregnancy but
can’t remember the
names
– Remembers “a lot of
pills” (yellow and white
)
– Her daughter is HIV
negative
– She stopped her meds
after delivering
17
18. Case Two: Janice
• On initial history:
– Has been feeling tired for about 3
months
– Intermittent night
sweats, intermittent pain with
swallowing ROS otherwise negative
– Family history
• Mother A&W with HTN, DM2, Father
Deceased from MI
• One daughter, 3 yrs old
– Surgical Hx includes C-Section 3 yrs
ago
– ED visit 6 months ago for GI
symptoms
– Allergic to Sulfa
– GYN: G2 P1, SAB X1, irregular
menses, LMP 2 months ago
18
19. Case Two: Janice
• What other information do we want to know about Janice?
• HIV History
– Viral Load was undetectable while on meds, thinks her
CD4 count was around 200, had a lot of GI side effects
with the meds, but never missed any doses.
• ETOH, Illicit Drugs
– Denies any alcohol or drug use. Does not smoke
• Sexual Activity
– Has a monogamous male partner, who is HIV negative.
They use condoms 100% of the time.
• Work History
– Full time work at small PR firm, does not have insurance
because she doesn’t want anyone at work to know about
her HIV.
• Immunizations
– Unknown, had a PPD from OB which was negative
• Mental Health History
– Was treated for depression 5 years ago after her father passed
away (x 1 year) 19
20. Case Two: Janice
• Physical Exam
– WNWD, NAD, BMI 24, VS: BP 144/90
otherwise wnl
– Well healed surgical scar from C-section
– White coating noted on posterior
oropharynx, scrapable with tongue
depressor
– Otherwise unremarkable
20
21. Case Two: Janice
• What Lab Tests Do We Want to Order?
– CD4 count
– Viral Load
– CMP/CBC
– Hepatitis Serologies (HAV, HBV, HCV)
– Urinalysis
– Genotype
– Fasting Plasma Glucose, Fasting Lipids
– RPR, GC/CT
– PPD
– Pregnancy Test
– Anti-Toxoplasma IgG
21
22. Case Two: Janice
• Results
– CBC Hgb: 8.7, Hct: 30, Plt 75,000, CMP: WNL
– CD4 75, VL is 132,675
– HBV sAg neg, anti HBc Ab negative, anti HBVs
Ab positive, HAV total Ab postive, anti HCV Ab
neg.
– Genotype is pan-sensitive
– Lipids: TC-175, LDL-98, HDL-40, TG-130. FPG: 98
– Urine Pregnancy test, negative, UA wnl
– PPD 0mm
– G6PD <3 U/g Hb
– Anti-toxoplasma IgG <6.5 IU/ml
22
23. Case Two: Janice
Does Janice needs PCP prophylaxis
(Audience Response)?
1. Yes
2. No
3. Maybe So
23
24. Case Two: Janice
What is the best option for PCP Prophylaxis for Janice
(Audience Response)?
1. Dapsone 100mg 1 tablet daily
1. Bactrim DS 1 tablet daily
1. Bactrim DS 1 tablet Q MWF
1. Mepron 1500 mg PO daily
1. Crossing your fingers
24
25. Case Two: Janice
Should Janice Start Antiretroviral Therapy
(Audience Response)?
1. Yes
2. No
3. Maybe So
25
26. Case Two: Janice
• What ARV’s Would You
Recommend for Janice?
– Her genotype is pan-
sensitive
– You show her a medication
chart in your office and she
identifies Combivir and
Kaletra as her previous
regimen
26
27. Case Two: Janice
What ARV’s Would You
Recommend for Janice?
(Audience Response)
1. Atripla (EFV/TDF/FTC)
2. Prezista, Norvir and
Truvada (DAR/r +
TDF/FTC)
3. Reyataz, Norvir and
Truvada (ATV/r
+TDF/FTC)
4. Isentress and Truvada
(RAL + TDF/FTC)
27
28. Case Two: Janice
• What are benefits and
risks of your selected ARV
regimen?
• If starting Janice at her
next visit, when do you
want her to return for
follow-up?
• How would you monitor
her response to therapy?
28
30. Case Three: Donna
• 53 year-old Caucasian female with HIV
infection
• She was diagnosed 2 years ago while
incarcerated.
• She was recently released from prison
and has not been treated for HIV in the
past. She is presenting today for
primary care/HIV Care
30
31. Case Three: Donna
• She has brought in her previous records from
prison
– CD4 count has been between 600 and 800 with a
nadir of 575 cells/mm3
– Viral Loads ~ 3,000 copies
– HBV sAg neg, anti HBc Ab negative, anti HBVs Ab
positive, HAV total Ab postive, anti HCV Ab neg.
– Genotype is pan-sensitive
– She also has hypertension and hypothyroid disease
for which she is taking:
• HCTZ 25 mg
• Lisinopril 20 mg
• Levothyroxine 100 mcg
– She has been taking prescriptions as above
31
32. Case Three: Donna
• On initial history:
– Has been feeling well in the past few months
– Is concerned about finding work and getting in touch
with family
– Family history
• Mother deceased from trauma, Father Deceased from
MI, Sister alive 49 with hypothyroid disease and high
cholesterol
• Two adult children whom she has little contact with, Alive and
Well as far as she knows
– Surgical Hx unremarkable
– NKDA
– GYN: G2 P2, LMP 5 years ago
32
33. Case Three: Donna
• What other information do we want to know about Donna?
• HIV History
– Previous HIV test 10 years ago which was negative. Risk factor is
heterosexual contact
• ETOH, Illicit Drugs
– Drinking 3-4 beers a day, no illicit drugs. Smokes ½ pack a
day
• Sexual Activity
– Has a monogamous female partner, who is HIV negative.
They use barrier protection 50% of the time
• Work History
– Previous work in retail. Is currently applying for jobs in the
area
• Immunizations
– UTD, had a PPD 9 mos ago which was negative
• Mental Health History
– Was treated for depression but has been off meds since she was
released
33
34. Case Three: Donna
• Physical Exam
– WNWD, NAD, BMI 28, VS: BP 128/84
otherwise wnl
– Unremarkable PE
34
35. Case Three: Donna
• What Lab Tests Do We Want to Order?
– CD4 count
– Viral Load
– CMP/CBC
– Urinalysis
– Fasting Plasma Glucose, Fasting Lipids
– RPR, GC/CT, PAP
– Anti-Toxoplasma IgG
35
37. Case Three: Donna
Should Donna Start Antiretroviral
Therapy? (Audience Response)
1. Yes
2. No
3. Maybe So
37
38. Case Three: Donna
• What ARV’s Would You Recommend for
Donna?
– Her genotype is pan-sensitive
– She is ARV Naïve
38
39. Case Three: Donna
What ARV’s Would You Recommend for
Donna? (Audience Response)
1. Atripla (EFV/TDF/FTC)
2. Prezista, Norvir and Truvada (DAR/r
+ TDF/FTC)
3. Reyataz, Norvir and Truvada (ATV/r
+TDF/FTC)
4. Isentress and Truvada (RAL +
TDF/FTC)
5. Complera (RPV/FTC/TDF)
39
40. Case Three: Donna
• What are benefits and risks of your selected
ARV regimen?
• If starting Donna at her next visit, when do
you want her to return for follow-up?
• How would you monitor her response to
therapy?
40
42. AETC NCHCMC Contacts
Clinical Team Contacts
Stephen Perez, RN, NP, AAHIVS, HIV Clinical Specialist
stephen@healthhiv.org
Mona Moore, PA-C, MA, AAHIVS, HIV Clinical Program Specialist
Kmona@healthhiv.org
42
43. HealthHIV
AETC NCHCMC
2000 S Street NW
Washington, DC 20009
www.NCHCMC.org
202-232-6749
Notas do Editor
What about an HLA-B5701 what about a co-recptor tropism assay?
What is Janice’s STAGE ACCORDING TO CDC STAGING. B3, she techincally does not have any AIDS indicator conditions, oropharyngeal thrush is not an aids indicator, but esophageal is. Does she need any opportunistic prophylaxis? Yes, for what? Should we take into account the G6PD finding? Can she be on Mepron?